Early inclisiran after heart attack trial
Part of Heart & circulation clinical trials.
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a heart attack (myocardial infarction)
- You have high cholesterol (dyslipidemia)
- Your first dose of the study drug must be within 9 to 19 days after your heart attack
- Your LDL cholesterol is very high if you have never taken statins, or still high even on statins
- You cannot have taken PCSK9 inhibitor drugs before
- You do not have severe liver disease or other serious health conditions affecting major organs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a new cholesterol-lowering drug, inclisiran, early during a hospital stay after a heart attack can help lower bad cholesterol (LDL) more effectively than usual care. It may reduce the risk of future heart problems.
This study tests a cholesterol-lowering injection (inclisiran) given soon after a heart attack, urgent heart procedure, or stroke. The goal is to see if it helps lower bad cholesterol quickly and safely.
This study tests an extra medication (inclisiran) added to your usual cholesterol-lowering treatment, compared to usual treatment alone, to see if it further lowers 'bad' cholesterol after a recent heart attack.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.